| Henderson, Randal H |
NCT04580667: Prospective Observational Exploratory Clinical Study to Determine the Assay Cut-Off for the RadTox Test in Prostate Cancer Patients to Predict Gastrointestinal Radiation Toxicity Using Circulating Cell Free DNA Directly From Plasma |
|
|
| Recruiting | N/A | 250 | US | Collection of plasma samples | DiaCarta, Inc. | Prostate Cancer | 09/23 | 12/23 | | |
PR06, NCT00969111: Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy |
|
|
| Recruiting | N/A | 70 | US | IMRT to 45 Gy; prostate bed proton boost of 21.6 CGE, Proton (prostate bed) to 70.2 CGE, IMRT to 45 Gy; proton boost to prostate bed to 25.2 CGE, Proton to 66.6 CGE | Proton Collaborative Group, University of Florida Health | Prostate Cancer | 08/31 | 08/50 | | |
NCT01368055: Hypofractionated Proton Radiation Therapy for Low and Intermediate Risk Prostate Cancer |
|
|
| Active, not recruiting | N/A | 361 | US | 70 Gy/CGE, 72.5 Gy/CGE | University of Florida | Prostate Cancer | 09/36 | 09/36 | | |
| Dagan, Roi |
NCT05268614: Risk Adapted De-Intensification of Radio-Chemotherapy for Oropharyngeal Squamous Cell Carcinoma |
|
|
| Recruiting | 2 | 250 | US | Radiation therapy, Cisplatin | University of Florida, Naveris, Inc. | Oropharyngeal Squamous Cell Carcinoma | 06/29 | 06/32 | | |
| Cacchio, Robin |
NCT04580667: Prospective Observational Exploratory Clinical Study to Determine the Assay Cut-Off for the RadTox Test in Prostate Cancer Patients to Predict Gastrointestinal Radiation Toxicity Using Circulating Cell Free DNA Directly From Plasma |
|
|
| Recruiting | N/A | 250 | US | Collection of plasma samples | DiaCarta, Inc. | Prostate Cancer | 09/23 | 12/23 | | |
| Gaskins, Jonathan |
NCT05268614: Risk Adapted De-Intensification of Radio-Chemotherapy for Oropharyngeal Squamous Cell Carcinoma |
|
|
| Recruiting | 2 | 250 | US | Radiation therapy, Cisplatin | University of Florida, Naveris, Inc. | Oropharyngeal Squamous Cell Carcinoma | 06/29 | 06/32 | | |
